| Elizabeth A Kadar, NP-C | |
|
811 W Main St Ste 209, Lexington, SC 29072-2500 | |
| (803) 358-6105 | |
| Not Available |
| Full Name | Elizabeth A Kadar |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 811 W Main St Ste 209, Lexington, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073010906 | NPI | - | NPPES |
| NP5337 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 21802 (South Carolina) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 21802 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospice Care Of South Carolina | Spartanburg, SC | Hospice |
| Lexington Medical Center | West columbia, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lexington Health Inc | 2567872070 | 753 |
| Sc House Calls Inc | 6800994807 | 358 |
News Archive
-18 Corp., through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today released an online overview video presented by Dr. John Salstrom, President and CEO of Protectus Medical Devices.
The identification of an insect-specific metal-sensing receptor in the gut lining highlights a possible new way to curb populations of disease-transmitting insects such as mosquitoes.
Today, public health and medical experts from the U.S. Department of Health and Human Services released the following statement on the Administration's plan for COVID-19 booster shots for the American people.
UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.
An international review team has prepared a Cochrane systematic review to assess the accuracy of a point-of-care urine test for diagnosing and screening tuberculosis (TB) in people living with human immunodeficiency virus (HIV).
› Verified 3 days ago
| Entity Name | Sc House Calls Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518048859 PECOS PAC ID: 6800994807 Enrollment ID: O20070613000821 |
News Archive
-18 Corp., through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today released an online overview video presented by Dr. John Salstrom, President and CEO of Protectus Medical Devices.
The identification of an insect-specific metal-sensing receptor in the gut lining highlights a possible new way to curb populations of disease-transmitting insects such as mosquitoes.
Today, public health and medical experts from the U.S. Department of Health and Human Services released the following statement on the Administration's plan for COVID-19 booster shots for the American people.
UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.
An international review team has prepared a Cochrane systematic review to assess the accuracy of a point-of-care urine test for diagnosing and screening tuberculosis (TB) in people living with human immunodeficiency virus (HIV).
› Verified 3 days ago
| Entity Name | Lexington Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710634753 PECOS PAC ID: 2567872070 Enrollment ID: O20201208000922 |
News Archive
-18 Corp., through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today released an online overview video presented by Dr. John Salstrom, President and CEO of Protectus Medical Devices.
The identification of an insect-specific metal-sensing receptor in the gut lining highlights a possible new way to curb populations of disease-transmitting insects such as mosquitoes.
Today, public health and medical experts from the U.S. Department of Health and Human Services released the following statement on the Administration's plan for COVID-19 booster shots for the American people.
UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.
An international review team has prepared a Cochrane systematic review to assess the accuracy of a point-of-care urine test for diagnosing and screening tuberculosis (TB) in people living with human immunodeficiency virus (HIV).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth A Kadar, NP-C 111 Doctor Cir, Columbia, SC 29203-6502 Ph: (800) 491-0909 | Elizabeth A Kadar, NP-C 811 W Main St Ste 209, Lexington, SC 29072-2500 Ph: (803) 358-6105 |
News Archive
-18 Corp., through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today released an online overview video presented by Dr. John Salstrom, President and CEO of Protectus Medical Devices.
The identification of an insect-specific metal-sensing receptor in the gut lining highlights a possible new way to curb populations of disease-transmitting insects such as mosquitoes.
Today, public health and medical experts from the U.S. Department of Health and Human Services released the following statement on the Administration's plan for COVID-19 booster shots for the American people.
UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.
An international review team has prepared a Cochrane systematic review to assess the accuracy of a point-of-care urine test for diagnosing and screening tuberculosis (TB) in people living with human immunodeficiency virus (HIV).
› Verified 3 days ago
Victoria Fenters, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1316 N Lake Dr, Lexington, SC 29072 Phone: 803-358-1191 | |
Dr. Brooke Patterson, DNP, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 815 Old Cherokee Rd, Lexington, SC 29072 Phone: 803-359-5181 | |
Mrs. Carolyn Birchmore, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1316 N Lake Dr, Lexington, SC 29072 Phone: 803-358-1191 Fax: 803-358-1180 | |
Amy Loper, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 811 W Main St Ste 207, Lexington, SC 29072 Phone: 803-358-6420 | |
Mrs. Willetta Rozena Jacobs, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1847 S Lake Dr, Lexington, SC 29073 Phone: 803-356-8998 | |
Donna Marie Bridger, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2480 Two Notch Rd, Lexington, SC 29072 Phone: 803-951-5871 Fax: 803-951-5882 | |
Emilee Rikard Campbell, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 811 W Main St Ste 201&209, Lexington, SC 29072 Phone: 803-785-4777 Fax: 803-358-6240 |